InVivo Therapeutics Holdings Corp. (NVIV) Fell -5.26% or -0.11 To Price $1.98 On Friday

InVivo Therapeutics Holdings Corp. (NVIV) fell -5.26% or -0.11 to $1.98. It is nearly 99335 shares traded, which is 35.02% compare to the average total volume 283624. The market cap of NVIV is $15.37 million. The year to date change is -96.08%. The 52 week price range is from $1.63 to $33.75. Price of NVIV have changed 1.95% during last week. It have changed 2.96% over last month, 6.09% over last 3 months, -74.36% over last 6 months and -93.31% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVIV is 2.00. It is 1.01% above current price. The 200-day Moving Averages for NVIV is 6.37. It is 221.72% above current price. The 52-week High is 33.75. It is 1604.55% from the current price. The 52-week Low is 1.63. It is -17.68% from current price.

There are some statistics of NVIV. It is has market cap $15.37 million. The share outstanding is 7.76 million. The average volume is 283624. It has 17.17M cash and 960000 in debt. The percent of top 15 Institution holding is 3.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVIV is -362.91%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVIV is -132.31%.


Share this post